Skip to main content
. 2023 Apr 19;9(5):e15211. doi: 10.1016/j.heliyon.2023.e15211

Table 1.

Summary results of seroconversion following SARS-CoV-2 vaccination.

Sample collection Tested Seroconversion (SARS CoV2 Spike IgG)a
21–25 days after dose 1 96 69 (71.9%)b
21–25 days after dose 2 47 45 (95.7%)b
a

ELISA detection of anti-SPIKE IgG§-SARS-CoV-2 in blood serum.

b

Displayed are the number of individuals and the percentage of seroconverted among the tested individuals.